Latest Announcements

BSE & NSE corporate filings with AI summaries

BSECompany UpdateResults4 Aug 2026

GlaxoSmithKline Pharmaceuticals Ltd

As per attachment

GlaxoSmithKline Pharmaceuticals Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue from operations at ₹92.44 crore and net profit at ₹25.33 crore. The company has also appointed Mr. Ronak Shah as Associate Fund Manager - Fixed Income, effective August 3, 2026.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults4 Aug 2026

Saregama India Ltd

Investor Presentation - Q1 FY 2026-27

Saregama India Ltd reported Q1 FY 2026-27 results with 27% YoY revenue growth, 69% YoY growth in Adjusted EBITDA, and 38% YoY growth in PBT. Music revenue grew 39% YoY, driven by licensing, artiste management, and retail. Live events revenue grew 214% YoY, driven by multi-format strategy. Video revenue declined due to pivot away from own film production.

Read more →📎 1 attachment
BSEBoard MeetingResults4 Aug 2026

Marathon Nextgen Realty Ltd

Marathon Nextgen Realty Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 ,inter alia, to consider and approve the Unaudited Financial ....

Marathon Nextgen Realty Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 07/08/2026 to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2026.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults4 Aug 2026

Saregama India Ltd

Revenue from Operations at INR 2,636 Mn (27% YoY growth), Adjusted EBITDA at INR 1,124 Mn (69% YoY growth) and PBT at INR 705 Mn (38% YoY growth)

Saregama India Ltd announced its Q1 FY27 financial results, with revenue from operations at INR 2,636 Mn (27% YoY growth), adjusted EBITDA at INR 1,124 Mn (69% YoY growth) and PBT at INR 705 Mn (38% YoY growth). The company reported a 39% YoY growth in music revenue and a 214% YoY growth in live events revenue.

Read more →📎 1 attachment
BSEAGM/EGMResults4 Aug 2026

Uniroyal Marine Exports Ltd

Voting results and Scrutinizers Report of the 34th AGM of the Company

Uniroyal Marine Exports Ltd held its 34th Annual General Meeting (AGM) on August 3, 2026, through video conferencing. The meeting was attended by 35 shareholders, including 1 promoter and 34 public shareholders. The resolutions passed included the adoption of the audited standalone financial statements for the financial year ended March 31, 2026, and the re-appointment of Mr. Thomas Kadakketh Chandy as a director liable to retire by rotation. The voting results showed that all resolutions were passed with the requisite majority.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults4 Aug 2026

Zydus Wellness Ltd-$

Press Release

Zydus Wellness Ltd reported a 66.7% growth in Net Sales for Q1 FY 27, with EBITDA and Net Profit growth of 55.3% and 0.2% respectively. The company's core brands, Sugar Free and Glucon-D, maintained their leadership positions in their respective categories.

Read more →📎 1 attachment
BSECompany UpdateResults4 Aug 2026

Chemplast Sanmar Ltd

Intimation - Earnings conference call invite

Chemplast Sanmar Ltd has announced an earnings conference call to discuss its operational and financial performance for Q1 FY27. The call is scheduled for August 7, 2026, at 11:00 AM IST. The company has provided access numbers for participants, including international toll-free numbers. The call will be attended by the Managing Director, Chief Financial Officer, Business Head, and Executive Director, Finance.

Read more →📎 1 attachment
BSEBoard MeetingResults4 Aug 2026

Lasa Supergenerics Ltd

Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve Pursuant to Regulation 29 ....

Lasa Supergenerics Ltd has scheduled a board meeting on August 14, 2026, to consider and approve unaudited financial results for the quarter ended June 30, 2026. The trading window remains closed till 48 hours after the declaration of results.

Read more →📎 1 attachment
BSECompany UpdateResults4 Aug 2026

Saregama India Ltd

Intimation with regards to Regulation 30(5) for Change in Authorization of KMPs for Determining the Materiality of Any Event or Information for the Purpose of making disclosure to Stock Exchanges.

Saregama India Ltd has announced the outcome of its board meeting, where it approved unaudited financial results for the quarter ended June 30, 2026. The company has also authorized its key managerial personnel to determine materiality of events or information for stock exchange disclosures.

Read more →📎 1 attachment
← PreviousPage 876 of 1288Next →